National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 152152

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

Already in VAERS on 12/31/2003

VAERS ID: 152152
VAERS Form:
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-06-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: RECOMBIVAX HB / MSD - / 0 - / IM
HEPA: VAQTA / MSD - / 0 - / IM

Administered by: Private      Purchased by: Unknown
Symptoms: LIVER FUNC ABNORM

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type':

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s persisted for two months before the pt recovered and the levels returned to baseli"ne. No further information is available.


Changed on 12/30/2006

VAERS ID: 152152 Before After
VAERS Form:
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-06-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: RECOMBIVAX HB / MSD - / 0 - / IM
HEPA: VAQTA / MSD - / 0 - / IM

Administered by: Private      Purchased by: Unknown
Symptoms: LIVER FUNC ABNORM

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type':

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s LFT''''s persisted for two months before the pt recovered and the levels returned to baseli"ne. basel"ine. No further information is available.


Changed on 12/8/2009

VAERS ID: 152152 Before After
VAERS Form:
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-06-13 2000-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: RECOMBIVAX HB HEP B (RECOMBIVAX HB) / MSD MERCK & CO. INC. - / 0 - / IM
HEPA: VAQTA HEP A (VAQTA) / MSD MERCK & CO. INC. - 0884H / 0 - / IM

Administered by: Private      Purchased by: Unknown Private
Symptoms: Liver function test abnormal, LIVER FUNC ABNORM

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type': (blank) WAES99060885

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''''s LFT''s persisted for two months before the pt recovered and the levels returned to basel"ine. baseline. No further information is available.


Changed on 9/14/2017

VAERS ID: 152152 Before After
VAERS Form:(blank) 1
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / 0 1 - / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0884H / 0 1 - / IM

Administered by: Private      Purchased by: Private
Symptoms: Liver function test abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type': WAES99060885

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s persisted for two months before the pt recovered and the levels returned to baseline. No further information is available.


Changed on 2/14/2018

VAERS ID: 152152 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / 1 - / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0884H / 1 - / IM

Administered by: Private      Purchased by: Private
Symptoms: Liver function test abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type': WAES99060885

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s persisted for two months before the pt recovered and the levels returned to baseline. No further information is available.


Changed on 6/14/2018

VAERS ID: 152152 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / 1 - / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0884H / 1 - / IM

Administered by: Private      Purchased by: Private
Symptoms: Liver function test abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type': WAES99060885

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s persisted for two months before the pt recovered and the levels returned to baseline. No further information is available.


Changed on 8/14/2018

VAERS ID: 152152 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / 1 - / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0884H / 1 - / IM

Administered by: Private      Purchased by: Private
Symptoms: Liver function test abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type': WAES99060885

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s persisted for two months before the pt recovered and the levels returned to baseline. No further information is available.


Changed on 9/14/2018

VAERS ID: 152152 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / 1 - / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0884H / 1 - / IM

Administered by: Private      Purchased by: Private
Symptoms: Liver function test abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type': WAES99060885

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s persisted for two months before the pt recovered and the levels returned to baseline. No further information is available.


Changed on 10/14/2018

VAERS ID: 152152 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / 1 - / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0884H / 1 - / IM

Administered by: Private      Purchased by: Private
Symptoms: Liver function test abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type': WAES99060885

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s persisted for two months before the pt recovered and the levels returned to baseline. No further information is available.


Changed on 12/24/2020

VAERS ID: 152152 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / 1 - / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0884H / 1 - / IM

Administered by: Private      Purchased by: Private
Symptoms: Liver function test abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type': WAES99060885

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s persisted for two months before the pt recovered and the levels returned to baseline. No further information is available.


Changed on 12/30/2020

VAERS ID: 152152 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / 1 - / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0884H / 1 - / IM

Administered by: Private      Purchased by: Private
Symptoms: Liver function test abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type': WAES99060885

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s persisted for two months before the pt recovered and the levels returned to baseline. No further information is available.


Changed on 5/7/2021

VAERS ID: 152152 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / 1 - / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0884H / 1 - / IM

Administered by: Private      Purchased by: Private
Symptoms: Liver function test abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type': WAES99060885

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s persisted for two months before the pt recovered and the levels returned to baseline. No further information is available.


Changed on 5/21/2021

VAERS ID: 152152 Before After
VAERS Form:1
Age:68.0
Sex:Female
Location:Texas
Vaccinated:1999-04-29
Onset:0000-00-00
Submitted:2000-03-07
Entered:2000-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / 1 - / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 0884H / 1 - / IM

Administered by: Private      Purchased by: Private
Symptoms: Liver function test abnormal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tenormin, Detrol
Current Illness:
Preexisting Conditions: hepatitis C
Allergies:
Diagnostic Lab Data: hepatic function test - worsening
CDC 'Split Type': WAES99060885

Write-up: Following vaccines, the pt experienced a worsening of liver function tests and was hospitalized. Therapy with tolterodine and atenolol were discontinued. The elevated LFT''s persisted for two months before the pt recovered and the levels returned to baseline. No further information is available.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=152152&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166